Stockreport

Johnson & Johnson highlights psoriasis candidate with long-term data [Seeking Alpha]

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com
PDF Last month, citing previewed data, the pharma giant said JNJ-2113, an oral IL-23 receptor blocker, reached all the primary and secondary endpoints in FRONTIER 1 in adul [Read more]